France Self-Monitoring Blood Glucose Devices Market Size and Share
Market Overview
| Study Period | 2021 - 2032 |
|---|---|
| Forecast Data Period | 2027 - 2032 |
| Historical Data Period | 2021 - 2025 |
| Base Year Market Size (2026) | USD 611.14 Million |
| Market Size (2027) | USD 655.02 Million |
| Market Size (2032) | USD 926.45 Million |
| Growth Rate (2027 - 2032) | 7.18 % |
Major Players *Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. | |
France Self-Monitoring Blood Glucose Devices Market Analysis by Mordor Intelligence
The France Self-Monitoring Blood Glucose Devices Market size is projected to be USD 611.14 million in 2026, USD 655.02 million in 2027, and reach USD 926.45 million by 2032, growing at a CAGR of 7.18% from 2027 to 2032.
In France, self-monitoring of blood glucose increases patients’ awareness of their glucose levels, supporting informed lifestyle choices. Monitoring results provide feedback and guidance that help patients make necessary behavioral changes. Persistently elevated blood glucose levels in patients with diabetes can lead to progressive complications, including renal, neurological, and ocular damage. Timely and appropriate self-monitoring of blood glucose enables the effective management of out-of-range glucose levels, thereby reducing diabetes-related health complications.
Innovative technologies, including digital health applications that display and summarize individual blood glucose measurements, can further support self-management in France. These applications may also integrate relevant data, such as insulin doses, meals and snacks, and physical activity, helping reduce disease burden and improve overall diabetes care. The integration of self-monitoring blood glucose devices with insulin calculators, automated insulin titration software, and remote coaching provides additional support for patients with poorly controlled diabetes. These developments can improve critical health outcomes and support the growth of the France self-monitoring blood glucose devices market over the coming years.
Note: Market numbers in this report are based on Mordor Intelligence's proprietary estimation framework, which combines nine months of actuals with Q4 projections for base year 2026.
France Self-Monitoring Blood Glucose Devices Market Trends and Insights
Rising Diabetes Prevalence in France
The diabetes population in France is expected to grow by about 2.9% over the forecast period.
According to the International Diabetes Federation's reports, the prevalence of diabetes in adults in France was approximately 8.6%. Self-monitoring is a commitment that many diabetic patients make to manage their condition. The blood glucose levels help the patients and doctors modify their diet, lifestyle, insulin therapy, and medications to help their blood sugar return to normal. With newer innovations in medical technology, glucometers these days have highly sensitive strips and sensors that can detect every component of blood accurately, close to lab results.
The French health benefit basket plays an important role; diabetes is one of the 30 chronic diseases covered 100% by statutory health insurance pursuant to the ALD scheme (affections de longue durée). For those not covered under ALD, a share of the official health care tariff is paid by the patient and varies depending on the category of goods and care.
Therefore, the studied market is anticipated to witness growth over the analysis period due to rising prevalence and the aforementioned factors.
The Test Strips Segment holds the highest market share in the current year
The test strip segment holds the highest market share of about 79.5% in the France self-monitoring blood glucose devices market in the current year.
Blood glucose test strips are small, disposable components essential to self-monitoring blood glucose testing in France. When blood is applied to a test strip, it reacts with glucose oxidase, a chemical that converts glucose in the blood into gluconic acid. The blood glucose meter then transfers an electric current to the strip. Electric terminals on the strip enable the meter to measure the current between them, which varies according to the amount of gluconic acid produced. The meter uses an algorithm to calculate the blood glucose level based on these changes in current. These devices enable individuals with diabetes to monitor their blood glucose levels regularly and support day-to-day disease management outside clinical settings.
In the France self-monitoring blood glucose devices market, test strips are expected to record higher market share growth than glucose meters due to their more frequent use. A glucometer is typically a one-time purchase, whereas test strips represent a recurring expense because users must dispose of each strip after a single use. An average glucose meter lasts between six months and three years, resulting in a one-time cost over this period. The recurring requirement for test strips is expected to support their continued demand in the France self-monitoring blood glucose devices market.
The French healthcare system (Protection Universelle Maladie) is mostly funded by taxes and offers partial health insurance. Usually, employers sign up their employees for social contributions, and a premium is deducted from their salaries through taxes. Whenever someone requires medical attention, up to 70% of their medical costs are already covered by national health insurance, and 100% in the case of someone dealing with a long-term condition like cancer or diabetes.
Therefore, owing to the aforesaid factors, the growth of the studied market is anticipated over the forecast period.
Competitive Landscape
The French self-monitoring blood glucose device market is fragmented, with a few significant and other generic players. Manufacturers like Abbott, LifeScan, Roche, Ascensia, etc. occupy a major share.
France Self-Monitoring Blood Glucose Devices Industry Leaders
-
Roche Diabetes Care
-
Abbott Diabetes Care
-
Ascensia Diabetes Care
-
LifeScan
-
Arkray
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- January 2023: LifeScan announced that the peer-reviewed Journal of Diabetes Science and Technology published Improved Glycemic Control Using a Bluetooth-Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World Evidence From Over 144,000 People With Diabetes, detailing results from a retrospective analysis of real-world data from over 144,000 people with diabetes-one of the largest combined blood glucose meter and mobile diabetes app datasets ever published.
- January 2022: Roche launched its new point-of-care blood glucose monitor designed for hospital professionals, with a companion device shaped like a touchscreen smartphone that would run its own apps. The hand-held Cobas Pulse includes an automated glucose test strip reader as well as a camera and touchscreen for logging other diagnostic results. It's designed to be used with patients of all ages, including neonates and people in intensive care.
France Self-Monitoring Blood Glucose Devices Market Report Scope
Self-monitoring of blood glucose is an approach used by diabetic patients to measure their blood sugar level themselves using a glucometer, test strips, and lancets. Based on the readings, patients can adjust or check the effect of their treatment. The French self-monitoring blood glucose device market is segmented by components. The report offers the value (in USD) and volume (in unit) for the above segments.
| Glucometer Devices |
| Test Strips |
| Lancets |
| Component | Glucometer Devices |
| Test Strips | |
| Lancets |
Key Questions Answered in the Report
How big is the France Self-Monitoring Blood Glucose Devices Market?
The France Self-Monitoring Blood Glucose Devices Market size is expected to USD 655.02 million in 2027 and grow at a CAGR of 7.18% to reach USD 926.45 million by 2032.
What is the current France Self-Monitoring Blood Glucose Devices Market size?
In 2026, the France Self-Monitoring Blood Glucose Devices Market size is expected to reach USD 611.14 million.
Who are the key players in France Self-Monitoring Blood Glucose Devices Market?
Roche Diabetes Care, Abbott Diabetes Care, Ascensia Diabetes Care, LifeScan and Arkray are the major companies operating in the France Self-Monitoring Blood Glucose Devices Market.
What years does this France Self-Monitoring Blood Glucose Devices Market cover, and what was the market size in 2025?
In 2025, the France Self-Monitoring Blood Glucose Devices Market size accounted for USD 570.20 million. The report covers the France Self-Monitoring Blood Glucose Devices Market het size for years: 2021, 2022, 2023, 2024, and 2025. The report also forecasts the France Self-Monitoring Blood Glucose Devices Market size for years: 2027, 2028, 2029, 2030, 2031, and 2032.